Current and future approaches for control of graft-versus-host disease

Sirolimus in Combination with Tacrolimus in Allogeneic Stem Cell Transplantation—Timing and Conditioning Regimen May Be Crucial

(2008) Daniel Wolff et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

140: Bortezomib Plus Tacrolimus/Methotrexate for Prophylaxis of Acute GVHD after HLA Mismatched Allogeneic Non-Myeloablative Transplantation: Results of a Dose Finding Phase I Study

(2008) J. Koreth et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Sirolimus in Combination with Cyclosporine or Tacrolimus Plus Methotrexate for Prevention of Graft-versus-Host Disease following Hematopoietic Cell Transplantation from Unrelated Donors

(2008) Terry Furlong et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

(2008) Leo Luznik et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells

(2008) E. Gatza et al.   BLOOD

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

(2008) Katarina Le Blanc et al.   LANCET

The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study

(2008) H Ning et al.   LEUKEMIA